Targeted Treatments for Hormone Receptor-Positive Breast Cancer
There were some noteworthy developments this year in targeted therapies for hormone receptor-positive breast cancer.
Author: Lisa DeFerrari
I'm a cancer research advocate who was diagnosed with breast cancer more than 20 years ago at age 35. I write about developments in cancer research from the patient perspective on my blog, After 20 Years.
Summer 2019 Blogging Challenge
I’m participating in a blogging challenge in which participants respond to a series of random questions about themselves and blogging.
Making Breast Cancer Prevention a Priority
A recent competition called on researchers and advocates to propose their best, bold ideas for how to prevent breast cancer.
Breast Cancer: Are We Still Making Progress?
What stands out in progress against breast cancer over the last five years, and where do we need to do more?
Breast Cancer Treatment: The TAILORx Clinical Trial
Findings from the TAILORx clinical trial will help personalize treatment decisions for many patients with early stage breast cancer.
5 Cancer Research Stories Worth Following – Spring 2018
Researchers are working on ways to make immune system therapies more effective for more cancer patients.
Making Healthcare More Affordable: Review of “An American Sickness” by Elisabeth Rosenthal
In ‘An American Sickness’, Elisabeth Rosenthal explains why our healthcare costs are out of control and offers practical steps we can take as individuals as well as a blueprint for reforms.
5 Cancer Research Stories Worth Following – Winter 2018
Cancer research stories worth following this winter included reports on new approaches to immunotherapy currently being tested in clinical trials.
5 Cancer Research Stories Worth Following – Fall 2017
Recent cancer research stories worth following include a study on post-traumatic stress disorder after a cancer diagnosis.
Genetic Testing for Cancer Risk: My Experience and What I Learned
What my experience with genetic testing was like and some of the helpful things I learned in the process.
After 20 Years 